Tryptophan Sleep Randomized Trial Evidence Table

Structured evidence table for Tryptophan Sleep Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Tryptophan Sleep Randomized TrialIncreasing evidence suggests that CFS involves not only peripheral metabolic and gastrointestinal abnormalities but also central nervous system dysfunction.2Jin M (2026)Tuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations.
Tryptophan Sleep Randomized TrialBackground Chronic fatigue syndrome (CFS) is a disabling multisystem disorder characterized by persistent fatigue, post-exertional malaise, unrefreshing sleep, and neurocognitive and gastrointestinal symptoms.2Jin M (2026)Tuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations.
Tryptophan Sleep Randomized TrialHigh-altitude-specific evidence for both behavioral and pharmacological treatments therefore remains limited.3Yang Huaxiucairang (2026)Hypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
Tryptophan Sleep Randomized Trial26–28 29–31 32 Against this neuroendocrine background, microbiota-derived signals may influence sleep and CNS function through metabolic, immune, and neural mechanisms.Human observational studies have reported differences in gut microbial composition, metabolic function, and microbiota-associated inflammatory profiles between individuals with insomnia and healthy controls.3Yang Huaxiucairang (2026)Hypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
Tryptophan Sleep Randomized TrialHence, this review consolidates current evidence on how HA hypoxia remodels the GBA to trigger or worsen insomnia, identifies translational obstacles, evaluates emerging intervention strategies, and outlines a research roadmap for microbiota-focused approaches in low-oxygen populations.3Yang Huaxiucairang (2026)Hypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
Tryptophan Sleep Randomized Trial1 2–4 5 6 7 8 9 10 11 12 High-altitude (HA) environments, typically defined as elevations exceeding 2500 meters, present significant physiological challenges to the human body due to hypobaric hypoxia.3Yang Huaxiucairang (2026)Hypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
topicTryptophan Sleep Randomized Trial
claimIncreasing evidence suggests that CFS involves not only peripheral metabolic and gastrointestinal abnormalities but also central nervous system dysfunction.
evidence level2
citationJin M (2026)
sourceTuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations.
topicTryptophan Sleep Randomized Trial
claimBackground Chronic fatigue syndrome (CFS) is a disabling multisystem disorder characterized by persistent fatigue, post-exertional malaise, unrefreshing sleep, and neurocognitive and gastrointestinal symptoms.
evidence level2
citationJin M (2026)
sourceTuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations.
topicTryptophan Sleep Randomized Trial
claimHigh-altitude-specific evidence for both behavioral and pharmacological treatments therefore remains limited.
evidence level3
citationYang Huaxiucairang (2026)
sourceHypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
topicTryptophan Sleep Randomized Trial
claim26–28 29–31 32 Against this neuroendocrine background, microbiota-derived signals may influence sleep and CNS function through metabolic, immune, and neural mechanisms.Human observational studies have reported differences in gut microbial composition, metabolic function, and microbiota-associated inflammatory profiles between individuals with insomnia and healthy controls.
evidence level3
citationYang Huaxiucairang (2026)
sourceHypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
topicTryptophan Sleep Randomized Trial
claimHence, this review consolidates current evidence on how HA hypoxia remodels the GBA to trigger or worsen insomnia, identifies translational obstacles, evaluates emerging intervention strategies, and outlines a research roadmap for microbiota-focused approaches in low-oxygen populations.
evidence level3
citationYang Huaxiucairang (2026)
sourceHypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective
topicTryptophan Sleep Randomized Trial
claim1 2–4 5 6 7 8 9 10 11 12 High-altitude (HA) environments, typically defined as elevations exceeding 2500 meters, present significant physiological challenges to the human body due to hypobaric hypoxia.
evidence level3
citationYang Huaxiucairang (2026)
sourceHypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective

Source documents

  1. Tuina for chronic fatigue syndrome: study protocol for a randomized controlled trial integrating tryptophan metabolism, gut microbiota, and brain network alterations.
  2. Hypoxia-Induced Gut-Brain Axis Remodeling and Insomnia: Mechanisms and Microbiota Adaptive Regulation from a Translational Perspective